Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients

Summary

Primary: Effect on HbA1c over 6 months in drug-naive patients with type 2 diabetes Secondary: Effect on glucose, insulin, C-peptide, insulin resistance, body weight, HDL-cholesterol, triglycerides, blood pressure - Safety, tolerability

Timeline

Start

2005-03

Primary completion

2006-06

Completion

2006-06

Drugs

Indications